Pricing
Login
Home
Charts
Search
Watchlist
Products

Jenburkt Pharmaceuticals Ltd

JENBURPH
₹893.20-0.79%20 Nov 2026
Reports
Pharma Others

Jenburkt Pharmaceuticals Ltd

JENBURPH
₹893.20
-0.79%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹394Cr
Close
Close Price
₹893.20
Industry
Industry
Pharma Others
PE
Price To Earnings
11.99
PS
Price To Sales
2.30
Revenue
Revenue
₹171Cr
Rev Gr TTM
Revenue Growth TTM
7.83%
PAT Gr TTM
PAT Growth TTM
-0.36%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
363933413741364643453648
Growth YoY
Revenue Growth YoY%
3.110.311.57.73.55.79.210.516.68.7-0.16.1
Expenses
ExpensesCr
282923302830273236302935
Operating Profit
Operating ProfitCr
710911911913714613
OPM
OPM%
20.225.428.627.723.926.525.228.817.331.916.926.9
Other Income
Other IncomeCr
111222222022
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
810101310121014814714
Tax
TaxCr
223333242314
PAT
PATCr
5871079810611610
Growth YoY
PAT Growth YoY%
-0.624.138.231.120.68.45.05.8-8.927.1-24.40.5
NPM
NPM%
15.120.322.823.317.620.821.922.313.824.316.621.1
EPS
EPS₹
12.317.916.821.814.819.317.723.013.424.613.323.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
363933413741364643453648
Growth YoY
Revenue Growth YoY%
3.110.311.57.73.55.79.210.516.68.7-0.16.1
Expenses
ExpensesCr
282923302830273236302935
Operating Profit
Operating ProfitCr
710911911913714613
OPM
OPM%
20.225.428.627.723.926.525.228.817.331.916.926.9
Other Income
Other IncomeCr
111222222022
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
810101310121014814714
Tax
TaxCr
223333242314
PAT
PATCr
5871079810611610
Growth YoY
PAT Growth YoY%
-0.624.138.231.120.68.45.05.8-8.927.1-24.40.5
NPM
NPM%
15.120.322.823.317.620.821.922.313.824.316.621.1
EPS
EPS₹
12.317.916.821.814.819.317.723.013.424.613.323.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
94103115123119109124137142152169171
Growth
Revenue Growth%
9.810.411.07.0-3.1-8.113.410.33.86.811.27.8
Expenses
ExpensesCr
77849198998997106109111125131
Operating Profit
Operating ProfitCr
162024252020273033404441
OPM
OPM%
17.619.120.720.416.618.122.022.223.326.625.923.7
Other Income
Other IncomeCr
333344555766
Interest Expense
Interest ExpenseCr
000010000001
Depreciation
DepreciationCr
222122222333
PBT
PBTCr
172025272122303335444743
Tax
TaxCr
678765889121210
PAT
PATCr
111417201517222526323533
Growth
PAT Growth%
11.725.327.415.0-24.911.035.110.45.623.48.3-0.4
NPM
NPM%
11.513.115.016.112.515.118.018.018.321.120.619.2
EPS
EPS₹
23.229.137.543.132.436.048.653.958.972.778.774.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
94103115123119109124137142152169171
Growth
Revenue Growth%
9.810.411.07.0-3.1-8.113.410.33.86.811.27.8
Expenses
ExpensesCr
77849198998997106109111125131
Operating Profit
Operating ProfitCr
162024252020273033404441
OPM
OPM%
17.619.120.720.416.618.122.022.223.326.625.923.7
Other Income
Other IncomeCr
333344555766
Interest Expense
Interest ExpenseCr
000010000001
Depreciation
DepreciationCr
222122222333
PBT
PBTCr
172025272122303335444743
Tax
TaxCr
678765889121210
PAT
PATCr
111417201517222526323533
Growth
PAT Growth%
11.725.327.415.0-24.911.035.110.45.623.48.3-0.4
NPM
NPM%
11.513.115.016.112.515.118.018.018.321.120.619.2
EPS
EPS₹
23.229.137.543.132.436.048.653.958.972.778.774.5
Sales CAGR
1 Year11%
3 Years7%
5 Years9%
TTM8%
EBITDA CAGR
1 Year8%
3 Years13%
5 Years17%
TTM-2%
PAT CAGR
1 Year8%
3 Years12%
5 Years16%
TTM0%
Avg. ROCE
1 Year24%
3 Years24%
5 Years25%
TTM21%
CFO / EBITDA
1 Year61%
3 Years53%
5 Years51%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555544444
Reserves
ReservesCr
365057737594113118141167193201
Current Liabilities
Current LiabilitiesCr
141813232018211616192324
Non Current Liabilities
Non Current LiabilitiesCr
443355444666
Total Liabilities
Total LiabilitiesCr
587677103104121143142165196226235
Current Assets
Current AssetsCr
45646690908076811105795121
Non Current Assets
Non Current AssetsCr
131312131541676155140131114
Total Assets
Total AssetsCr
587677103104121143142165196226235
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555544444
Reserves
ReservesCr
365057737594113118141167193201
Current Liabilities
Current LiabilitiesCr
141813232018211616192324
Non Current Liabilities
Non Current LiabilitiesCr
443355444666
Total Liabilities
Total LiabilitiesCr
587677103104121143142165196226235
Current Assets
Current AssetsCr
45646690908076811105795121
Non Current Assets
Non Current AssetsCr
131312131541676155140131114
Total Assets
Total AssetsCr
587677103104121143142165196226235

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8101613151991782827
Investing Cash Flow
Investing Cash FlowCr
0-101-11-3-19-13-1-17-19
Financing Cash Flow
Financing Cash FlowCr
-51-18-2-11-1-6-21-7-8-9
Net Cash Flow
Net Cash FlowCr
21-10103-103-2
Free Cash Flow
Free Cash FlowCr
510161111187156813
CFO To PAT
CFO To PAT%
72.573.794.065.6101.0117.941.669.331.387.076.3
CFO To EBITDA
CFO To EBITDA%
47.550.568.052.076.198.034.056.124.569.160.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8101613151991782827
Investing Cash Flow
Investing Cash FlowCr
0-101-11-3-19-13-1-17-19
Financing Cash Flow
Financing Cash FlowCr
-51-18-2-11-1-6-21-7-8-9
Net Cash Flow
Net Cash FlowCr
21-10103-103-2
Free Cash Flow
Free Cash FlowCr
510161111187156813
CFO To PAT
CFO To PAT%
72.573.794.065.6101.0117.941.669.331.387.076.3
CFO To EBITDA
CFO To EBITDA%
47.550.568.052.076.198.034.056.124.569.160.6

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
209223281232146183260294304446422394
Price To Earnings
Price To Earnings
20.716.516.311.79.811.111.711.911.713.912.112.0
Price To Sales
Price To Sales
2.22.22.51.91.21.72.12.12.12.92.52.3
Price To Book
Price To Book
5.24.14.63.01.81.92.22.42.12.62.11.9
EV To EBITDA
EV To EBITDA
11.39.510.17.54.66.68.08.06.810.58.58.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
68.569.169.169.069.269.771.072.275.577.277.577.5
OPM
OPM%
17.619.120.720.416.618.122.022.223.326.625.923.7
NPM
NPM%
11.513.115.016.112.515.118.018.018.321.120.619.2
ROCE
ROCE%
37.734.441.831.826.021.424.426.524.525.323.621.3
ROE
ROE%
26.824.828.125.618.616.819.020.117.918.717.616.0
ROA
ROA%
18.617.722.219.314.313.615.617.415.716.315.414.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
209223281232146183260294304446422394
Price To Earnings
Price To Earnings
20.716.516.311.79.811.111.711.911.713.912.112.0
Price To Sales
Price To Sales
2.22.22.51.91.21.72.12.12.12.92.52.3
Price To Book
Price To Book
5.24.14.63.01.81.92.22.42.12.62.11.9
EV To EBITDA
EV To EBITDA
11.39.510.17.54.66.68.08.06.810.58.58.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
68.569.169.169.069.269.771.072.275.577.277.577.5
OPM
OPM%
17.619.120.720.416.618.122.022.223.326.625.923.7
NPM
NPM%
11.513.115.016.112.515.118.018.018.321.120.619.2
ROCE
ROCE%
37.734.441.831.826.021.424.426.524.525.323.621.3
ROE
ROE%
26.824.828.125.618.616.819.020.117.918.717.616.0
ROA
ROA%
18.617.722.219.314.313.615.617.415.716.315.414.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews